TIN is focused on advancing Therapies and Treatments to benefit those living with an Inherited Neuropathy. As a group, these are known as Charcot-Marie-Tooth (CMT) disorders.

Therapies for Inherited Neuropathies is a registered 501(C)(3) health organization, focused on improving the lives of people with Charcot-Marie-Tooth disease

Solutions Now

Physical therapy videos and articles dedicated to expert insights on the latest treatment options, and practical therapies designed to improve mobility, reduce symptoms, and enhance daily life.

Help on the Way

TIN is dedicated to advancing research initiatives to better understand, diagnose, and treat CMT. Collaborating with researchers, clinicians, and the CMT community, we aim to accelerate innovative therapies for those living with CMT.
1:2500

CMT affects 1 in 2500 people, meaning more than three million people world-wide are affected with Charcot Marie Tooth (CMT)

2

Current treatment options are limited to bracing, and surgery in some cases

130,000+

Those affected in the US population. CMT impacts those of all ages, sex, faith or race

Proud of the company we keep

Our Board members and Advisors have made a commitment to contribute their expert skills to a common goal: Improving the lives of members of the CMT community
Steve O’Donnell

Founder & CEO

Tom Haslach

Board of Directors

Steve O’Connell

Board of Directors

Jimmy Reyes

Board of Directors

Bob Shaffer

Board of Directors

David Todd

Board of Directors

Mark Scheideler, Ph.D.

Chief Science Officer

Mario Bortolozzi, Ph.D.

Advisory Board

Scott Heinlein

Advisory Board

Jon Lai, Ph.D.

Advisory Board

Rudolf Martini, Ph.D.

Advisory Board

Wendy Quitasol

Advisory Board

E. Richard Stanley, Ph.D.

Advisory Board

Mike Studer, P.T., M.H.S.

Advisory Board

Therapies for Inherited Neuropathies
PO Box 5630 Baltimore, MD 21210
© 2025 Therapies for Inherited Neuropathies. All rights reserved. Website by CWD.